What is DexCom's revenue?

DexCom (DXCM) generated $4.8B in revenue over the trailing twelve months, up 16.2% year over year.

Is DexCom profitable?

DexCom reported $930.4M in net income over the trailing twelve months, a 19.3% net margin.

What are DexCom's profit margins?

Gross margin is 61.5% and operating margin is 21.4%, with a 19.3% net margin.

What is DexCom's earnings per share?

DexCom's diluted EPS over the trailing twelve months is $2.33.

Where does DexCom's income statement data come from?

Every line is extracted from DexCom's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

DexCom DXCM Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$4.82B+3.3%	$4.66B+3.2%	$4.52B+5.0%	$4.3B+3.7%	$4.15B+2.9%
Total cost of revenue	$1.85B-0.3%	$1.86B+0.5%	$1.85B+4.4%	$1.77B+5.4%	$1.68B+5.5%
Gross profit	$2.96B+5.8%	$2.8B+5.1%	$2.67B+5.4%	$2.53B+2.5%	$2.47B+1.1%
Gross margin	61.5%+1.4pp	60.1%+1.1pp	59%+0.2pp	58.8%-0.7pp	59.4%-1.0pp
Research and development	$599.2M0.0%	$599.1M+1.5%	$590.4M+3.9%	$568.3M+2.2%	$556.1M+0.7%
Selling, general and administrative	$1.33B+3.1%	$1.29B-0.5%	$1.3B+2.0%	$1.27B-0.4%	$1.28B-0.7%
Total operating expenses	$1.93B+2.1%	$1.89B+0.1%	$1.89B+2.6%	$1.84B+0.4%	$1.83B-0.3%
Operating income	$1.03B+13.3%	$911.8M+17.2%	$777.7M+13.2%	$687.2M+8.6%	$632.6M+5.4%
Operating margin	21.4%+1.9pp	19.6%+2.3pp	17.2%+1.2pp	16%+0.7pp	15.3%+0.4pp
Other income (expense), net	$170.2M-3.6%	$176.6M-2.6%	$181.3M+87.1%	$96.9M-1.3%	$98.2M-9.9%
Income before income taxes	$1.2B+10.6%	$1.09B+13.5%	$959M+22.3%	$784.1M+7.3%	$730.8M+3.1%
Income tax expense	$273.2M+8.4%	$252.1M+5.8%	$238.3M+12.1%	$212.6M+8.7%	$195.6M+47.3%
Net income	$930.4M+11.3%	$836.3M+16.0%	$720.7M+26.1%	$571.5M+6.8%	$535.2M-7.1%
Net margin	19.3%+1.4pp	17.9%+2.0pp	16%+2.7pp	13.3%+0.4pp	12.9%-1.4pp
Diluted earnings per share	$2.33+11.5%	$2.09+16.1%	$1.80+25.0%	$1.44+7.5%	$1.34-6.3%
EBITDA	$1.29B+11.1%	$1.16B+13.8%	$1.02B+10.7%	$923.3M+7.6%	$857.8M+4.9%
EBITDA margin	26.8%+1.9pp	25%+2.3pp	22.6%+1.2pp	21.5%+0.8pp	20.7%+0.4pp
EBIT	$1.03B+13.3%	$911.8M+17.2%	$777.7M+13.2%	$687.2M+8.6%	$632.6M+5.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about DexCom.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is DexCom's revenue?: DexCom (DXCM) generated $4.8B in revenue over the trailing twelve months, up 16.2% year over year.
Is DexCom profitable?: DexCom reported $930.4M in net income over the trailing twelve months, a 19.3% net margin.
What are DexCom's profit margins?: Gross margin is 61.5% and operating margin is 21.4%, with a 19.3% net margin.
What is DexCom's earnings per share?: DexCom's diluted EPS over the trailing twelve months is $2.33.
Where does DexCom's income statement data come from?: Every line is extracted from DexCom's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.